State of Wisconsin Investment Board’s MoonLake Immunotherapeutics MLTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Buy	12,598 +160	+1%	+$2.65K	﹤0.01%	2306
2025 Q4	$164K	Sell	12,438 -274	-2%	-$3.23K	﹤0.01%	2292
2025 Q3	$91.1K	Sell	12,712 -237	-2%	-$12.4K	﹤0.01%	2330
2025 Q2	$611K	Buy	12,949 +91	+0.7%	+$3.71K	﹤0.01%	1777
2025 Q1	$502K	Sell	12,858 -7	-0.1%	-$302	﹤0.01%	1756
2024 Q4	$697K	Sell	12,865 -164	-1%	-$8.37K	﹤0.01%	1665
2024 Q3	$657K	Buy	13,029 +473	+4%	+$22.2K	﹤0.01%	1745
2024 Q2	$552K	Sell	12,556 -828	-6%	-$35.1K	﹤0.01%	1776
2024 Q1	$672K	Sell	13,384 -1,712	-11%	-$92.9K	﹤0.01%	1592
2023 Q4	$912K	Sell	15,096 -514	-3%	-$26.5K	﹤0.01%	1422
2023 Q3	$890K	Buy	+15,610	New	+$862K	﹤0.01%	1440

Other funds holding MLTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of Wisconsin Investment Board's MLTX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its MoonLake Immunotherapeutics (MLTX) stake by 1.3% in Q1 2026, buying an estimated $2.65K and bringing the position to 12,598 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

State of Wisconsin Investment Board first reported a position in MLTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $912K in Q4 2023. 147 funds tracked by Wall St. Rank hold MLTX as of Q1 2026.

State of Wisconsin Investment Board held 12,598 shares of MoonLake Immunotherapeutics worth $235K as of Q1 2026.
State of Wisconsin Investment Board bought 160 MoonLake Immunotherapeutics shares in Q1 2026, an estimated $2.65K.
MoonLake Immunotherapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2306 holding.
State of Wisconsin Investment Board first reported a position in MoonLake Immunotherapeutics in Q3 2023 and has held it in 11 quarters since.
State of Wisconsin Investment Board's MoonLake Immunotherapeutics position peaked at $912K in Q4 2023.
147 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.